Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Francesco Oddone. (2022) Reviewing the evidence surrounding preservative-free tafluprost/timolol fixed-dose combination therapy in open-angle glaucoma and ocular hypertension management: a focus on efficacy, safety, and tolerability. Expert Opinion on Drug Safety 21:10, pages 1259-1268.
Read now
Read now
Mohammad Pakravan, Afsaneh Naderi Beni, Shahin Yazdani, Hamed Esfandiari & Shahram Mirshojaee. (2021) Efficacy and safety of timolol-dorzolamide fixed-combination three times a day versus two times a day in newly diagnosed open-angle glaucoma. Journal of Drug Assessment 10:1, pages 91-96.
Read now
Read now
Jack Phu, Ashish Agar, Henrietta Wang, Katherine Masselos & Michael Kalloniatis. (2021) Management of open‐angle glaucoma by primary eye‐care practitioners: toward a personalised medicine approach. Clinical and Experimental Optometry 104:3, pages 367-384.
Read now
Read now
Articles from other publishers (34)
Anne Hedengran & Miriam Kolko. (2023) The molecular aspect of anti-glaucomatous eye drops - are we harming our patients?. Molecular Aspects of Medicine 93, pages 101195.
Crossref
Crossref
Kornelia E. C. Andorfer, Florian Zeman, Michael Koller, Judith Zeller, René Fischer, Caroline T. Seebauer, Veronika Vielsmeier, Christopher Bohr & Thomas S. Kühnel. (2022) TIMolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (TIM-HHT)—A Prospective, Randomized, Double-Blind, Controlled, Cross-Over Trial. Pharmaceutics 14:11, pages 2335.
Crossref
Crossref
N. A. Bakunina & L. N. Kolesnikova. (2022) The life style of glaucoma patients: a scientific rationale for basic recommendations. Russian Ophthalmological Journal 15:3, pages 150-156.
Crossref
Crossref
Siphokazi B. K. Dludla, Leshasha T. Mashabela, Brian Ng’andwe, Pedzisai A. Makoni & Bwalya A. Witika. (2022) Current Advances in Nano-Based and Polymeric Stimuli-Responsive Drug Delivery Targeting the Ocular Microenvironment: A Review and Envisaged Future Perspectives. Polymers 14:17, pages 3580.
Crossref
Crossref
Shishir Rao, Yikuan Li, Rema Ramakrishnan, Abdelaali Hassaine, Dexter CanoyJohn Cleland, Thomas LukasiewiczGholamreza Salimi-KhorshidiKazem Rahimi. (2022) An Explainable Transformer-Based Deep Learning Model for the Prediction of Incident Heart Failure. IEEE Journal of Biomedical and Health Informatics 26:7, pages 3362-3372.
Crossref
Crossref
Michael Rode, Kolja Nenoff, Kerstin Wirkner, Katrin Horn, Andrej Teren, Ralf Regenthal, Markus Loeffler, Joachim Thiery, Achim Aigner, Janne Pott, Holger Kirsten & Markus Scholz. (2022) Impact of medication on blood transcriptome reveals off-target regulations of beta-blockers. PLOS ONE 17:4, pages e0266897.
Crossref
Crossref
Hang Yi, Yu Feng & Heather Gappa-Fahlenkamp. (2022) Analysis of topical dosing and administration effects on ocular drug delivery in a human eyeball model using computational fluid dynamics. Computers in Biology and Medicine 141, pages 105016.
Crossref
Crossref
Sapna Sinha, Wesam Shamseldin Shalaby, Wendy W. Liu, Reza Razeghinejad & L. Jay Katz. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
612
661
.
Yara P. Catoira-Boyle, Darrell WuDunn, Louis B. Cantor, John T. Lind, Elizabeth Ann Martin & Steve L. Gerber. 2022. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology
2331
2399
.
Yuta Saito, Junichiro Kizaki, Yoshihiro Wada, Yoshiyuki Shibasaki, Nobuharu Kishimoto & Makoto Aihara. (2021) Comparison of the 24-h efficacy and safety of fixed combination carteolol/latanoprost and timolol/latanoprost in patients with primary open-angle glaucoma and ocular hypertension: a prospective crossover study. Japanese Journal of Ophthalmology 65:5, pages 598-607.
Crossref
Crossref
Xueqi Lin, Xingdi Wu, Xiang Chen, Ben Wang & Wen Xu. (2021) Intellective and stimuli-responsive drug delivery systems in eyes. International Journal of Pharmaceutics 602, pages 120591.
Crossref
Crossref
Riku Arai, Daisuke Fukamachi, Masaki Monden, Naotaka Akutsu, Nobuhiro Murata & Yasuo Okumura. (2021) Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease. Internal Medicine 60:1, pages 79-83.
Crossref
Crossref
Daniel J. Yoon, Ramanjot Kaur, Anthony Gallegos, Kaitlyn West, Hsinya Yang, Saul Schaefer, Catherine Tchanque-Fossuo, Sara E. Dahle & R. Rivkah Isseroff. (2020) Repurposing Ophthalmologic Timolol for Dermatologic Use: Caveats and Historical Review of Adverse Events. American Journal of Clinical Dermatology 22:1, pages 89-99.
Crossref
Crossref
L. V. Yakubova, S. M. Kosakyan & L. V. Vasilenkova. (2020) Sustainable treatment of glaucoma patients with cardiovascular diseases. Russian Ophthalmological Journal 13:3, pages 103-107.
Crossref
Crossref
Ankita R. Desai, Furqan A. Maulvi, Ditixa M. Desai, Manish R. Shukla, Ketan M. Ranch, Bhavin A. Vyas, Shailesh A. Shah, Susan Sandeman & Dinesh O. Shah. (2020) Multiple drug delivery from the drug-implants-laden silicone contact lens: Addressing the issue of burst drug release. Materials Science and Engineering: C 112, pages 110885.
Crossref
Crossref
Ludovic Jean Wrobel, Angèle Gayet-Ageron & Frédérique-Anne Le Gal. (2020) Effects of Beta-Blockers on Melanoma Microenvironment and Disease Survival in Human. Cancers 12:5, pages 1094.
Crossref
Crossref
Sergio Esteban-Pérez, Vanessa Andrés-Guerrero, José Javier López-Cano, Irene Molina-Martínez, Rocio Herrero-Vanrell & Irene Bravo-Osuna. (2020) Gelatin Nanoparticles-HPMC Hybrid System for Effective Ocular Topical Administration of Antihypertensive Agents. Pharmaceutics 12:4, pages 306.
Crossref
Crossref
Doina Gherghel. (2020) The use of ophthalmic medications in pregnancy: What should we know?. Optician 2020:2, pages 8224-1.
Crossref
Crossref
Yara P. Catoira-Boyle, Darrell WuDunn, Louis B. Cantor, John T. Lind, Elizabeth Ann Martin & Steve L. Gerber. 2020. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology
1
69
.
Zhuoying Wang, Ian Denys, Feng Chen, Lijie Cai, Xuecui Wang, Daniel R. Kapusta, Yongliang Lv & Juan Gao. (2019) Complete atrioventricular block due to timolol eye drops: a case report and literature review. BMC Pharmacology and Toxicology 20:1.
Crossref
Crossref
Anthony Cole GallegosMichael James DavisCatherine N. Tchanque-FossuoKaitlyn WestAngela Eisentrout-MeltonThomas R. PeavyRoy W. DixonRoma P. PatelSara Evona DahleRoslyn Rivkah Isseroff. (2019) Absorption and Safety of Topically Applied Timolol for Treatment of Chronic Cutaneous Wounds. Advances in Wound Care 8:11, pages 538-545.
Crossref
Crossref
Corina Bello, Adriaan van Rensburg, Massimiliano Meineri & Markus M. Luedi. (2019) Eye Drops. A & A Practice 13:4, pages 155-157.
Crossref
Crossref
Taieb Aouak, Wassem Sharaf Saeed, Nawaf M. Al-Hafi, Abdel-Basit Al-Odayni, Abdulaziz Ali Alghamdi & Idriss Bedja. (2019) Poly (2-hydroxyethylmethacrylate –co–methylmethacrylate)/Lignocaine Contact Lens Preparation, Characterization, and in vitro Release Dynamic. Polymers 11:5, pages 917.
Crossref
Crossref
Karen E. SamyYiqi CaoJean KimNina Rosa Konichi da SilvaAudrey PhoneMichele M. BloomerRobert B. BhisitkulTejal A. Desai. (2019) Co-Delivery of Timolol and Brimonidine with a Polymer Thin-Film Intraocular Device. Journal of Ocular Pharmacology and Therapeutics 35:2, pages 124-131.
Crossref
Crossref
V. P. Erichev & A. S. Makarova. (2019) Сompatibility of Systemic Drugs and Local Antihypertensive Therapy in Patients with Primary Open-Angle Glaucoma (Analytical Review). Ophthalmology in Russia 15:4, pages 366-373.
Crossref
Crossref
Parul Ichhpujani. 2019. Glaucoma. Glaucoma
47
64
.
Changhua Mu, Meng Shi, Ping Liu, Lu Chen & Gerard Marriott. (2018) Daylight-Mediated, Passive, and Sustained Release of the Glaucoma Drug Timolol from a Contact Lens. ACS Central Science 4:12, pages 1677-1687.
Crossref
Crossref
Anthony Gallegos, Thomas Peavy, Roy Dixon & Roslyn Rivkah Isseroff. (2018) Development of a novel ion-pairing UPLC method with cation-exchange solid-phase extraction for determination of free timolol in human plasma. Journal of Chromatography B 1096, pages 228-235.
Crossref
Crossref
Tsontcho Ianchulev, Robert Weinreb, James C Tsai, Shan Lin & Louis R Pasquale. (2018) High-precision piezo-ejection ocular microdosing: Phase II study on local and systemic effects of topical phenylephrine. Therapeutic Delivery 9:1, pages 17-27.
Crossref
Crossref
Lisa V. Stottlemyer & Victoria L. Dzurinko. 2018. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
595
607
.
Gábor Holló, Andreas Katsanos, Kostas G. Boboridis, Murat Irkec & Anastasios G. P. Konstas. (2017) Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages. Drugs 78:1, pages 39-64.
Crossref
Crossref
Anu Vaajanen & Heikki Vapaatalo. (2017) A Single Drop in the Eye – Effects on the Whole Body?. The Open Ophthalmology Journal 11:1, pages 305-314.
Crossref
Crossref
Ricardo Titze-de-Almeida, Catherine David & Simoneide Souza Titze-de-Almeida. (2017) The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market. Pharmaceutical Research 34:7, pages 1339-1363.
Crossref
Crossref
Petros Ioannou, Magdalini Velegraki, Stella Soundoulounaki, Achilleas Gikas & Diamantis P. Kofteridis. (2017) An Unexpected Cause of Bradycardia in a Patient with Bacterial Meningitis. Case Reports in Medicine 2017, pages 1-3.
Crossref
Crossref